Comparative Analysis of Outcome Following Liver Transplantation in US Veterans

American Journal of Transplantation

Volumn 4, Issue 5, 2004, Pages 788-795

  Austin, Gregory L ^a   Sasaki, Anna W ^a   Zaman, Atif ^a   Rabkin, John M ^b   Olyaei, Ali ^a   Ruimy, Roberta ^a,b   Orloff, Susan L ^b   Ham, John ^b   Rosen, Hugo R ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Hepatitis C; Liver transplantation; MELD (model for endstage liver disease); Outcomes

Indexed keywords

ADULT; AGE; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENDER; HAZARD; HEPATITIS C; HUMAN; KAPLAN MEIER METHOD; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MULTIVARIATE ANALYSIS; ORGAN DONOR; POPULATION; PRIORITY JOURNAL; SCORING SYSTEM; SOLDIER; TREATMENT OUTCOME; UNITED STATES; UNIVERSITY;

ADULT; FEMALE; HEPATITIS C; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RISK FACTORS; SURVIVAL RATE; UNITED STATES; VETERANS;

EID: 2442598373     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2004.00388.x     Document Type: Article

References (27)

1. Annual report of the US organ procurement and transplantation network and scientific registry of transplant recipients 2002. http://www.ustransplant.org/annual.html.
2. http://www.unos.org.
3. Austin GE, Jensen B, Leete et al. Prevalence of hepatitis C virus seropositivity among hospitalized US veterans. Am J Med Sci 2000; 319: 353-359.
4. Brau N, Bini EJ, Shahidi A et al. Prevalence of hepatitis C and coinfection with HIV among United States veterans in the New York City metropolitan area. Am J Gastroenterol 2002; 97: 2071-2078.
5. Rosen HR, Chou S, Sasaki AW, Gretch DR. Molecular epidemiology of hepatitis C infection in U.S. veteran liver transplant recipients: evidence for decreasing relative prevalence of genotype 1B. Am J Gastroenterol 1999; 94: 3015-3019.
6. Child CG, Turcotte JG. Surgery and portal hypertension. In:Child CG (ed). The Liver and Portal Hypertension. Philadelphia: Saunders; 1964. p. 50.
7. Pugh RN, Murray-Lyon IM, Dawson JI, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-649.
8. Kamath PS, Wiesner RH, Malinchoc M et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-470.
9. Van den Besselaar A. Precision and accuracy of the international normalized ratio in oral anticoagulant control. Haemostasis 1996; 26 (Suppl. 4): S248-S265.
10. Cox DR. Regression models and life tables. J Royal Stat Soc 1972; 34: 187-220.
11. Jain A, Reyes J, Kashyap R et al. Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg 2000; 232: 490-500.
12. Smith CM, Davies DB, McBride MA. Liver transplantation in the United States: a report from the Organ Procurement and Transplantation Network. Clin Transpl 2000, 19-30.
13. Collins BH, Pirsch JD, Becker YT et al. Long-term results of liver transplantation in older patients 60 years of age and older. Transplantation 2000; 70: 780-783.
14. Belle SH, Beringer KC, Detre KM. An update on liver transplantation in the United States. Recipient characteristics and outcome. Clin Transpl 1995, 19-33.
15. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-871.
16. Wiesner R, Edwards E, Freeman R et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91-96.
17. Nair S, Verma S, Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002; 35: 1179-1185.
18. Curevas-Mons V, Millan I, Gavaler JS, Starzl TE, Van Thiel DH. Prognostic value of preoperatively obtained clinical and laboratory data in predicting survival following orthotopic liver transplantation. Hepatology 1986; 6: 922-927.
19. Kim WR. Pretransplantation disease severity and posttransplantation outcome. Liver Transplant 2003; 9: 124-125.
20. Pruett TL. The allocation of livers for transplantation a problem of Titanic consideration. Hepatology 2002; 35: 960-963.
21. Forman LM, Lucey MR. Predicting the prognosis of chronic liver disease: an evolution from Child to MELD. Hepatology 2001; 33: 473-475.
22. Onaca NN, Levy MF, Sanchez EQ et al. A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transplant 2003; 9: 117-123.
23. Doyle HR, Marino IR, Morelli F et al. Assessing risk in liver transplantation. Special reference to the significance of a positive cytotoxic crossmatch. Ann Surg 1996; 224: 168-177.
24. Hoofnagle JH, Lombardero M, Zetterman RK et al. Donor age and outcome of liver transplantation. Hepatology 1996; 24: 89-96.
25. Charlton M, Seaberg E, Wiesner R et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998; 28: 823-830.
26. Zekry A, Whiting P, Crawford DH et al. and the Australian and New Zealand Liver Transplant Clinical Study Group. Liver transplantation for HCV-associated liver cirrhosis: predictors of outcomes in a population with significant genotype 3 and 4 distribution. Liver Transpl 2003; 9: 339-347.
27. Berenguer M, Prieto M, San Juan F et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002; 36: 202-210.